PIP5K1α inhibition as a therapeutic strategy for prostate cancer
Publication
, Journal Article
Drake, JM; Huang, J
Published in: Proceedings of the National Academy of Sciences of USA
2014
Duke Scholars
Published In
Proceedings of the National Academy of Sciences of USA
ISSN
1091-6490
Publication Date
2014
Publisher
National Academy of Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Drake, J. M., & Huang, J. (2014). PIP5K1α inhibition as a therapeutic strategy for prostate cancer. Proceedings of the National Academy of Sciences of USA.
Drake, J. M., and J. Huang. “PIP5K1α inhibition as a therapeutic strategy for prostate cancer.” Proceedings of the National Academy of Sciences of USA, 2014.
Drake JM, Huang J. PIP5K1α inhibition as a therapeutic strategy for prostate cancer. Proceedings of the National Academy of Sciences of USA. 2014;
Drake, J. M., and J. Huang. “PIP5K1α inhibition as a therapeutic strategy for prostate cancer.” Proceedings of the National Academy of Sciences of USA, National Academy of Sciences, 2014.
Drake JM, Huang J. PIP5K1α inhibition as a therapeutic strategy for prostate cancer. Proceedings of the National Academy of Sciences of USA. National Academy of Sciences; 2014;
Published In
Proceedings of the National Academy of Sciences of USA
ISSN
1091-6490
Publication Date
2014
Publisher
National Academy of Sciences